Background: We performed a single-center retrospective analysis to determine
The use of long-term left ventricular assist devices (LVADs) has grown exponentially over the past decade, and outcomes for patients with end-stage heart failure with LVADs have improved substantially. [8] [9] [10] Serum albumin levels in patients with advanced heart failure can be affected by many different factors including congestive hepatopathy, cardiorenal syndrome, malnutrition, and higher levels of systemic inflammation. Preoperative hypoalbuminemia has been associated with postoperative acute renal failure and prolonged hospitalization after LVAD implantation. 11 However, there are little data on the effect of preoperative albumin levels on overall survival and survival following bridge to transplantation. The aim of this study was to determine whether preoperative serum albumin level was associated with survival and adverse outcomes in patients who underwent continuous-flow (CF)-LVAD implantation and its effect on patients who are bridged to transplantation. Registry. 12 Early RHF was defined as occurring within 30 days of implantation, whereas late RHF was defined as occurring after 30 days.
| MATERIALS AND METHODS

| Data collection
| Patient data
Patient demographics and preoperative characteristics included sex, gender, body surface area (BSA), body mass index (BMI), cause of heart failure, previous sternotomy, preoperative inotrope use, preoperative short-term mechanical circulatory support, and INTERMACS profile.
Preoperative lab values were collected immediately before CF-LVAD implantation and included preoperative hemoglobin level, white blood cell count, and platelet count; serum levels of sodium, creatinine, blood urea nitrogen, liver enzymes, total bilirubin, and albumin; international normalized ratio; and associated comorbidities, including hypertension, 3 | RESULTS
| Demographics and preoperative characteristics of CF-LVAD recipients
During the study period, 526 patients underwent CF-LVAD implantation and were included in our analysis. Mean BMI of patients was 28.4 ± 2.7 with no significant difference between the normal and hypoalbuminemia groups (Table 1) . Mean preoperative serum albumin levels were 3.5 ± 0.6 g/dL (range 0.2-5.0 g/dL) ( Table 2 ).
| Incidence of in-hospital postoperative complications
Compared with patients with normal preoperative serum albumin levels, patients with hypoalbuminemia had a higher incidence of in-hospital postoperative ND (5.9% vs 10.8%, P = 0.04) and in-hospital postoperative infections (10.2% vs 18.1%, P = 0.008) and tended (P < 0.20) to have a higher incidence of all complications (Table 3) .
| Survival after CF-LVAD implantation
Kaplan-Meier survival analysis showed that patients with normal preoperative serum albumin levels had significantly higher overall survival and survival at 1, 6, 12, and 24 months post-LVAD implantation than the patients with moderate and severe preoperative hypoalbuminemia (P < 0.001; Figure 1 and Table 4 ). Kaplan-Meier analysis of patients who survived to discharge also demonstrated lower survival in patients with low serum albumin (P = 0.03, Figure 2 ).
Stratification of patients with hypoalbuminemia by serum prealbumin
concentration demonstrated significantly lower survival in patients with low prealbumin (P < 0.001) but not in those with normal prealbumin (P = 0.20, Figure 3A ) when compared with patients with normal serum albumin. Stratification of patients with hypoalbuminemia by CVP demonstrated significantly lower survival in patients with moderately and severely elevated CVP but not for those with normal CVP (P < 0.001, P = 0.003, and P = 0.95, respectively, Figure 3B ) when compared with patients with normal serum albumin. Analysis of primary cause of death showed that patients with hypoalbuminemia had a higher incidence of deaths from arrhythmias, renal failure, and ischemic stroke (Table 5) . FIGURE 2 Kaplan-Meier survival curve of patients who survived to discharge from index hospitalization
| Cox proportional hazard analysis of the effect of preoperative serum albumin levels on survival
Cox proportional hazard analysis demonstrated that a preoperative albumin level less than 3.5 g/dL was an independent predictor of postoperative mortality (P = 0.001). Other factors significantly associated with mortality included being destination therapy (P = 0.002) and a higher WBC count (P < 0.001; Table 6 ).
| Success of bridge to transplantation
Among bridge-to-transplant (BTT) patients (n = 283), hypoalbuminemia did not impact the success of bridging to transplant (P = 0.33, Table 7 ). Furthermore, hypoalbuminemia did not impact survival in BTT patients who were successfully transplanted (P = 0.95, Figure 4 ).
| DISCUSSION
The increased use of LVADs and extracorporal mechanical support (ECMO) has prompted interest in determining which groups of patients are more prone to increased perioperative complications and may not benefit from this more aggressive support. 13 While frailty has been identified as a potential risk factor for poor long-term survival, frailty alone may not identify patients at increased risk for adverse outcomes following cardiac surgical procedures. 14 In addition, the effects of FIGURE 3 Kaplan-Meier survival curve of patients with normal serum albumin (≥3.5 g/dL) and those with low serum albumin (<3.5 g/dL) stratified by (A) prealbumin, and (B) central venous pressure obesity have also been studied in LVAD patients, but BMI itself may not be an independent predictor of overall survival. 11 Serum albumin level may be a useful predictive tool because it is affected by several factors, including hepatic synthetic capability, catabolic state, tissue space distribution, and inflammation, which are related to a wide array of disease states and to overall health. [1] [2] [3] [4] Additionally, in the setting of malnutrition, hypoalbuminemia is a modifiable risk factor that could potentially be improved with aggressive nutritional supplementation.
Preoperative hypoalbuminemia has been well established as an independent predictor of mortality and postoperative complications in general cardiac procedures. 15 Hypoalbuminemia has also been associated with malnutrition, liver insufficiency, and congestive heart failure. 16 Other studies have associated low serum albumin levels Our results showed that moderate preoperative hypoalbuminemia (2.5-3.5 g/dL) and severe preoperative hypoalbuminemia (less than 2.5 mg/dL) were associated with significantly decreased survival after CF-LVAD implantation. Consistent with previous reports on general cardiac surgery patients, the incidence of postoperative adverse outcomes was also significantly greater among patients with hypoalbuminemia. These outcomes included ND, GI bleeding, infections, and AKI. We also demonstrated several significant differences in the preoperative demographics of patients with hypoalbuminemia, which suggest that albumin is an indicator of significant pre-existing co-morbidities that affect patient outcomes.
Hypoalbuminemia was significantly correlated with lower preoperative serum prealbumin levels, a more sensitive marker of malnutrition. 18, 19 There was no significant difference in survival between patients with normal serum albumin and those with hypoalbuminemia but normal prealbumin. Our data did not show a significant correlation between hypoalbuminemia and BMI, and several studies have shown no association between BMI and outcomes with CF-LVAD implantation. 11, [20] [21] [22] This may suggest that it is hypoalbuminemia and its underlying causes, and not BMI, that may be responsible for the increased morbidity and mortality observed in these patients.
Our data showed that hypoalbuminemia was significantly correlated with hyperbilirubinemia, elevated levels of liver function markers, and lower platelet counts which may suggest that congestive hepatopathy is another underlying mediator between hypoalbuminemia and mortality. We did not demonstrate a difference in survival between patients with normal serum albumin and those with hypoalbuminemia but normal CVP. Previous studies have found a link between hypoalbuminemia and end-stage liver disease; these studies have also linked end-stage liver disease to increased morbidity and mortality in LVAD patients. 23 However, early postoperative liver dysfunction has not been shown to affect mortality. Hypoalbuminemia at the time of CF-LVAD implantation did not have a significant impact on the success of bridging to transplantation and did not significantly affect survival after transplantation. Hence, serum albumin levels alone may not exclude patients from CF-LVAD implantation who are candidates for transplantation.
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Our study had several limitations. First, this study was retrospective and non-randomized. Second, because this study was based on a single-center experience, selection bias may have been present. Third, we did not address the effects of postoperative serum albumin level on mortality and other adverse outcomes, limiting our analysis to a preoperative assessment of the patient's status. Fourth, we did not assess the impact of perioperative nutritional supplementation in patients with hypoalbuminemia to determine its effects on improving patient survival and decreasing postoperative complications. Last, we did not investigate whether there were potential clustering effects by surgeon on outcomes.
In conclusion, our data demonstrated significantly reduced survival after CF-LVAD implantation for patients with preoperative moderate and/or severe hypoalbuminemia. Additionally, these patients had a higher incidence of GI bleeding, LVAD-related infections and sepsis, AKI, IND, and readmission than patients with normal preoperative albumin levels that may be linked to comorbidities, malnutrition, and/or congestive hepatopathy. However, we found no significant difference in survival when examining patients with hypoalbuminemia and normal prealbumin, and normal CVP. We also did not find significant differences in the success of bridging to transplantation or in survival after transplantation in hypoalbuminemic patients. Further studies are required to examine how preoperative albumin levels may be incorporated into the patient selection process for long-term LVAD therapy and whether preoperative nutritional supplementation will improve short-and long-term therapy in these patients.
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